Myelodysplastic syndromes trials in Sweden

In Sweden 9 Also abroad 369

9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Where
Gothenburg, Huddinge, Lund, Örebro
Age
18 years and over
People
225 worldwide
Run by
Takeda
See details and how to joinNCT06499285 · EU 2024-516009-22-00
Phase 3Taking people
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Where
Örebro
Age
18 years and over
People
490 worldwide
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT06641414 · EU 2024-517247-31-00
Phase 3Taking people
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Where
Gothenburg, Lund, Stockholm
Age
18 years and over
People
665 worldwide
Run by
Celgene
See details and how to joinNCT04064060
Phase 1/2Taking people
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Where
Stockholm
Age
18 years and over
People
250 worldwide
Run by
CellCentric Ltd.
See details and how to joinNCT04068597
Phase 2Taking people
NMDSG-14B2
Where
Goteborg, Huddinge, Linkoping, Lund, Umeå, Uppsala
Age
18 years and over
People
200 worldwide
Run by
Karolinska University Hospital
See details and how to join2024-511651-17-00 · EU 2024-511651-17-00
Phase 1/2Taking people
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Where
Huddinge
Age
18 years and over
People
240 worldwide
Run by
Aptose Biosciences Inc.
See details and how to joinNCT03850574 · EU 2023-503244-14-00
Phase 2Taking people
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
Where
Gothenburg, Linköping, Lund, Stockholm, Uppsala
Age
18 years to 45 years
People
100
Run by
Vastra Gotaland Region
See details and how to joinNCT06793410
Phase 2Taking people
Combining Active and Passive DNA Hypomethylation
Where
Gothenburg, Lund, Stockholm, Uppsala
Age
18 years and over
People
196 worldwide
Run by
Kirsten Grønbæk
See details and how to joinNCT03999723
Phase 2Taking people
A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS
Where
Stockholm
Age
18 years and over
People
200
Run by
Karolinska University Hospital
See details and how to joinNCT05788679